DESTINA Genomics Ltd is a biotech company founded in Edinburgh in 2011 by Hugh Ilyine, Juan J. Diaz-Mochon and Mark Bradley. In July 2012, a Spanish subsidiary DESTINA Genomica S.L. was created with the goal to accelerate a long-term growth plan. The company focused on the application and validation of its patented state-of-the-art technologies.
DESTINA has created a unique and reliable chemistry for highly specific detection of nucleic acids. It can be used to identify any known target nucleic acid sequence, and in particular can directly detect small RNA’s, without the multiple steps required by current methods.
To become a leading manufacturer and supplier of custom chemical reagents and technologies for ‘best in class’ nucleic acid based biomarker assays. DESTINA’s technology introduces cheaper, more accurate and much more meaningful Nucleic Acid Testing tools.
The two cities are centres for scientific excellence and innovation, particularly in the life sciences. Our location gives us unique access to the best of the University of Edinburgh and Granada, the Genyo Institute of Granada and a wide range of world class technology companies.